Loading...
Loading...
- Cigna Corp CI reports Q1 total revenues of $44.12 billion, +7.6% Y/Y, ahead of the consensus of $43.41 billion.
- Cigna brought in $1.18 billion in earnings, up from $1.16 billion a year ago.
- Q1 adjusted EPS reached $6.01 compared with $4.73 a year ago, beating the consensus of $5.18.
- By the end of 2021, Cigna boasted 107.4 million pharmacy benefit customers, a gain of 6.4 million over the year. Medical membership reached 17.78 million, up from 16.67 million a year ago.
- At its Evernorth subsidiary, revenues were up 10% Y/Y reaching $33.58 billion, reflecting organic growth in specialty pharmacy services.
- Revenues were up 3% at its health plan, reaching $11.39 billion.
- Guidance: For FY22, Cigna expects EPS of at least $22.60 (consensus of $22.49), up from prior guidance of at least $22.40
- It reaffirms FY22 revenues of at least $177 billion.
- For FY22, the Company expects total Medical Customer Growth (lives) of at least 725,000, up from the 575,000 anticipated earlier.
- Price Action: CI shares closed at $252.08 on Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in